Guardant Health Testing

#1 Alternative Cancer Treatment Center in North America

Guardant Health Testing

Screening to find cancer early, when it’s most treatable

TESTS FOR CANCER SCREENING
For asymptomatic adults at average risk of cancer, our blood test aims to ensure that all individuals eligible for cancer screening are screened. We believe that by offering an accurate, simple blood test, we can transform cancer screening and help increase compliance rates. We are starting with colorectal cancer, where screening rates can be improved, and will continue to expand to other cancer types.

Guardant Shield: A blood test to screen for early signs of cancer

Today, 1 in 3 adults are not completing the recommended colorectal cancer screening.21 A blood test can improve these rates by overcoming barriers associated with available methods, including colonoscopy and stool-based testing, which while effective, can be unpleasant, time-consuming and difficult to complete.

Guardant Shield: A blood test to screen for early signs of cancer

Today, 1 in 3 adults are not completing the recommended colorectal cancer screening.21 A blood test can improve these rates by overcoming barriers associated with available methods, including colonoscopy and stool-based testing, which while effective, can be unpleasant, time-consuming and difficult to complete.

Guardant Reveal: Improving the management of early-stage cancer

TESTS FOR PATIENTS WITH EARLY-STAGE CANCER
For doctors treating patients of early-stage cancer, two fundamental questions remain after surgery: Does any cancer remain? What is the risk of the cancer returning? Our test helps answer these questions by quickly and conveniently detecting minimal residual disease (MRD) from a simple blood draw.  

Residual disease detection and recurrence monitoring

Guardant Reveal™ is a revolutionary blood-only liquid biopsy test that detects circulating tumor DNA (ctDNA) for minimal residual disease (MRD) assessment in early-stage colorectal, breast, and lung cancers. In addition to detection of MRD, Guardant Reveal is also available to monitor recurrence in previously diagnosed patients. Guardant Reveal is covered for fee-for-service Medicare patients with Stage II or III CRC whose testing is initiated within three months following curative intent therapy.

Play Video
Welcome to Cancer Center for Healing
Play Video
New Patient Intro
Alternative Cancer Treatments Available in the USA

Located in Irvine, CA

Cancer Center For Healing is the largest multidisciplinary, Integrative cancer center in North America. Our facilities blend cutting-edge technology from around the world with personalized testing and treatments created by our leading cancer experts.

We are proud to provide the most comprehensive, technologically advanced, and scientifically based cancer protocols allowing our patients to review the highest quality of care without the need for international travel.

We’ve had the pleasure of helping thousands of cancer patients on their road to recovery. From prevention phases to Stage IV diagnoses, we’re always inspired by our patients’ dedication to healing. We’ve treated folks from all backgrounds and walks of life, and we’ve seen even the most dire cases reach and stay in remission with our treatments. Here are just a few of the inspirational testimonials and survivor stories we’ve witnessed at Cancer Center for Healing told by the patients themselves.

Play Video about Patient-Testimonial
Play Video
Play Video
Skip to content